147
Views
25
CrossRef citations to date
0
Altmetric
Review

Emerging and potential therapies for Alzheimer's disease

, BSc, , PhD & , PhD
Pages 693-704 | Published online: 15 May 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yifeng Jin, Daulat B. Khadka & Won-Jea Cho. (2016) Pharmacological effects of berberine and its derivatives: a patent update. Expert Opinion on Therapeutic Patents 26:2, pages 229-243.
Read now
Heledd H. Griffiths, Isobel J. Whitehouse & Nigel M. Hooper. (2012) Regulation of amyloid-β production by the prion protein. Prion 6:3, pages 217-222.
Read now
Anne Corbett & Clive Ballard. (2012) New and emerging treatments for Alzheimer's disease. Expert Opinion on Emerging Drugs 17:2, pages 147-156.
Read now
Anne Corbett, Jessica Smith & Clive Ballard. (2012) New and emerging treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics 12:5, pages 535-543.
Read now

Articles from other publishers (21)

Barbara Kramarz, Rachael P. Huntley, Milagros Rodríguez-López, Paola Roncaglia, Shirin C.C. Saverimuttu, Helen Parkinson, Rina Bandopadhyay, Maria-Jesus Martin, Sandra Orchard, Nigel M. Hooper, David Brough & Ruth C. Lovering. (2020) Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer’s Disease Gene Expression Data. Journal of Alzheimer's Disease 75:4, pages 1417-1435.
Crossref
Tooba Naz Shamsi, Teeba Athar, Romana Parveen & Sadaf Fatima. (2017) A review on protein misfolding, aggregation and strategies to prevent related ailments. International Journal of Biological Macromolecules 105, pages 993-1000.
Crossref
Md. Rashidur Rahman, Afsana Tajmim, Mohammad Ali & Mostakim Sharif. (2017) Overview and Current Status of Alzheimer’s Disease in Bangladesh. Journal of Alzheimer's Disease Reports 1:1, pages 27-42.
Crossref
Romana Parveen, Tooba Naz Shamsi & Sadaf Fatima. (2017) Nanoparticles-protein interaction: Role in protein aggregation and clinical implications. International Journal of Biological Macromolecules 94, pages 386-395.
Crossref
A. Hall & A.I. Velter. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 280 325 .
Jaspreet Kalra & Aamir Khan. (2015) Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease. European Journal of Pharmacology 764, pages 571-581.
Crossref
Jingying LiQiusen HanXinhuan Wang, Ning Yu, Lin YangRong YangChen Wang. (2014) Reduced Aggregation and Cytotoxicity of Amyloid Peptides by Graphene Oxide/Gold Nanocomposites Prepared by Pulsed Laser Ablation in Water. Small 10:21, pages 4386-4394.
Crossref
Qiutian Jia, Yulin Deng & Hong Qing. (2014) Potential Therapeutic Strategies for Alzheimer’s Disease Targeting or Beyond β -Amyloid: Insights from Clinical Trials . BioMed Research International 2014, pages 1-22.
Crossref
Adrian C. Lo, Ina Tesseur, David I.C. Scopes, Edmund Nerou, Zsuzsanna Callaerts-Vegh, Ben Vermaercke, J. Mark Treherne, Bart De Strooper & Rudi D'Hooge. (2013) Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500. Neuropharmacology 75, pages 458-466.
Crossref
Ghasem Ghasemi, Sattar Arshadi, Alireza Nemati Rashtehroodi, Mahyar Nirouei, Shahab Shariati & Zinab Rastgoo. (2013) QSAR Investigation on Quinolizidinyl Derivatives in Alzheimer’s Disease. Journal of Computational Medicine 2013, pages 1-8.
Crossref
Morteza Mahmoudi, Hamid R. Kalhor, Sophie Laurent & Iseult Lynch. (2013) Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale 5:7, pages 2570.
Crossref
Siva Sundara Kumar Durairajan, Liang-Feng Liu, Jia-Hong Lu, Lei-Lei Chen, Qiuju Yuan, Sookja K. Chung, Ling Huang, Xing-Shu Li, Jian-Dong Huang & Min Li. (2012) Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Neurobiology of Aging 33:12, pages 2903-2919.
Crossref
Joshua Close, Richard HeidebrechtJr.Jr., John Hendrix, Chaomin Li, Ben Munoz, Laura Surdi, Solomon Kattar, Paul Tempest, Paul Moses, Xiaoliu Geng, Bethany Hughes, Nadya Smotrov, Chris Moxham, Jennifer Chapnick, Ilona Kariv, George Nikov, Julie Elizabeth Burke, Sujal Deshmukh, Valentina Jeliazkova-Mecheva, John Kevin Leach, Damaris Diaz, Lin Xu, Ziping Yang, Gloria Kwei, Lily Moy, Sanjiv Shah, Flobert Tanga, Candia Kenefic, Dan Savage, Mark Shearman, Richard G. Ball, Michael J. McNevin, Amanda Markarewicz & Thomas Miller. (2012) Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters 22:9, pages 3203-3207.
Crossref
Krista Lanctôt, Ida Kircanski, Sarah Chau & Nathan Herrmann. 2012. Alzheimer's Disease. Alzheimer's Disease 117 161 .
Christiane Reitz. (2012) Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review. International Journal of Alzheimer's Disease 2012, pages 1-11.
Crossref
Nathan Herrmann, Sarah A. Chau, Ida Kircanski & Krista L. Lanctôt. (2011) Current and Emerging Drug Treatment Options for Alzheimerʼs Disease. Drugs 71:15, pages 2031-2065.
Crossref
Hadas Skaat, Gilead Shafir & Shlomo Margel. (2011) Acceleration and inhibition of amyloid-β fibril formation by peptide-conjugated fluorescent-maghemite nanoparticles. Journal of Nanoparticle Research 13:8, pages 3521-3534.
Crossref
Francesca Mangialasche, Alina Solomon, Bengt Winblad, Patrizia Mecocci & Miia Kivipelto. (2010) Alzheimer's disease: clinical trials and drug development. The Lancet Neurology 9:7, pages 702-716.
Crossref
Pengfei Ge, Yinan Luo, Haifeng Wang & Feng Ling. (2009) Anti-protein aggregation is a potential target for preventing delayed neuronal death after transient ischemia. Medical Hypotheses 73:6, pages 994-995.
Crossref
M. P. Burns, L. Zhang, G. W. Rebeck, H. W. Querfurth & C. E.-H. Moussa. (2009) Parkin promotes intracellular A 1-42 clearance. Human Molecular Genetics 18:17, pages 3206-3216.
Crossref
Li Fei & Sarah Perrett. (2009) Effect of Nanoparticles on Protein Folding and Fibrillogenesis. International Journal of Molecular Sciences 10:2, pages 646-655.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.